On September 5, 2023, the Ministry of Health published the Decree of June 9, 2023, on the adoption of the 2023-2025 National HTA Medical Devices Program.

On September 19, 2023, the Innovative Devices Access Pathway (IDAP) pilot was launched. IDAP program aimed to accelerate the development of cost-effective medical devices and their integration into the UK market. The application window to join the pilot phase is now open to the UK and international commercial and non-commercial developers of innovative health technology. The deadline is October 29, 2023. Eight products will be selected for the pilot phase and receive non-financial support from a team of experts.

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 19147 of September 6, 2023, Tuscany Regional Healthcare has published assessments of four medical devices in the peripheral vascular and dermatology areas.

In September 2023, the Health Sciences Institute in Aragon (IACS) is working on several HTAs, including evaluations in diagnostic imaging, endocrine, IVD, neuromodulation, orthopedics, peripheral vascular, and some other fields.

On September 12, 2023, an application window was opened to join the NHS Innovation Accelerator (NIA) program in 2024. NIA supports the development of individuals (‘Fellows’) and the spread of their innovation nationally. The deadline for applications is October 22, 2023.

In September 2023, the following method assessments were initiated as a part of a framework for the managed introduction of innovations "New Methods" for cardiovascular, e-health, endocrine, gastrointestinal, IVD, men’s health, neurology and neurosurgery, neuromodulation, robotic surgery, and some other fields.

Market access is a challenging field. Multiple priorities have to be managed within a limited budget. We would like to share the anonymized outlines of the projects in the HEOR and market access fields commissioned to MTRC to inspire our clients. The next example is the adaptation of the global models to settings of European countries.

At early September 2023, the new version of the classification of procedure codes (CCAM v.73) was published. Several changes were introduced, including the creation of two permanent codes, one provisionally registered code, and three new grouping codes for 280 dental procedures.

In September 2023, NHS England defined the roadmap and key dates for the next version of the OPCS-4 nomenclature of procedures, which is updated every three years. The applications for changes can be submitted no later than December 1, 2024, to be implemented in the OPCS-4.11 version from April 2026.

In September 2023, several ongoing mini-HTA assessments for e-health, gastrointestinal, IVD, neurology and neurosurgery, peripheral vascular, pulmonary and airways, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway.

The EUnetHTA 21 Consortium will cease operating on 16 September 2023. The HTA Regulation Secretariat at the European Commission will be the contact point for matters related to HTA collaboration under the HTAR.

Between late May and early September 2023, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 49 health apps are currently available in the DiGA Directory, and six health apps were delisted from the Directory.